Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
adjudicated, adult, aim, ASC, asymptomatic, ATM, Baxalta, began, boxed, buying, ceiling, chargeback, chemotherapeutic, Classification, CMO, conceived, constipation, constitute, contravention, cough, covenant, Cowen, creditworthy, crime, crizotinib, deadly, Deferral, deployment, Dineen, discontinuation, dispensed, distributor, district, dyspnea, EU, evolve, evolving, extinguishment, FCP, formula, foundation, FY, grace, grow, growing, grown, Guarantor, headache, HIPAA, host, HRSA, Hyperglycemia, inadvertent, incomplete, incorrect, incurrence, indefinite, inpatient, insignificant, Inspector, intentionally, Inter, inventory, irrespective, istiratumab, jointly, Keytruda, Korea, landscape, learned, left, lending, liaison, Lonsurf, MAA, malware, mandate, MERRIMACKTMand, moiety, mounted, NADAC, nascent, necessitated, nivolumab, noncurrent, notification, Oceania, ONIVYDE, Opdivo, outpace, overage, overcharge, overcharging, overwhelming, owed, page, pari, partner, partnered, passively, passu, pembrolizumab, permissible, permission, post, poverty, pre, premarket, prepayment, procurement, PROVYDETM, recalculation, redeem, redeemed, redemption, refund, regorafenib, Relief, reprioritization, resale, resell, retroactive, sequestration, shelf, Shire, social, sophistication, spent, Stivarga, Subtopic, survey, Taxpayer, teaching, TFDA, thereof, title, Topic, unamortized, undamaged, underage, unexercised, uninfringed, unopened, unstratified, untreated, unvested, VA, ventricular, vi, word, Xalkori, Yasir, Zealand
Removed:
absence, accretion, activation, acute, additively, advice, affinity, amortizing, andin, appeal, appealed, applicability, asin, attempted, authoritative, avoid, bladder, category, chance, Chinese, cholesterol, chromatography, classify, conceal, construed, culmination, degrade, developingin, disappearance, division, divisional, elderly, encapsulated, endeavor, engineered, enzyme, EP, epidermal, epitope, EPR, ER, estrogen, eventually, exceeding, experimental, extrusion, family, fehr, filter, fluctuate, forin, fraudulent, fulfilled, functionalin, genetically, gordon, hamster, hypothesize, imputed, induced, inhibiting, inhibition, introduction, inventive, Jumpstart, line, load, mediated, medically, Modernization, mutual, negotiation, neoadjuvant, noncash, nonvested, opposing, ourin, ovary, overexpression, oversee, pace, parallel, particularin, pathologic, pcr, PDMA, placein, platinum, possiblein, postmenopausal, predetermined, preferentially, prematurely, pretreatment, prime, principle, prioritize, progesterone, progressed, proportion, provisional, purify, qui, raw, reading, reassessed, referral, regression, regulatein, release, relieved, replication, reposition, resection, resistant, responded, revoking, secondarily, secrete, Shanghai, somein, statistical, synergistically, tam, tangible, thein, thesein, thought, topoisomerase, traditionally, ultrafiltration, unchanged, undergone, unnecessarily, upregulated, xenograft, Zensun
Filing tables
Filing exhibits
Related press release
MACK similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Forms S-3 (Nos. 333-186369 and 333-194312) and S-8 (Nos. 333-180996, 333-186370, 333-194313 and 333-202346) of Merrimack Pharmaceuticals, Inc. of our report dated February 26, 2016 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
Boston, Massachusetts
February 26, 2016